Home LiteratureArticle Details
PMID: 3934744 Published · ppublish English Journal Article Research Support, Non-U.S. Gov't

The postoperative fibrinolytic shutdown: a rapidly reverting acute phase pattern for the fast-acting inhibitor of tissue-type plasminogen activator after trauma.

Scandinavian journal of clinical and laboratory investigation ·Vol. 45 ·No. 7 ·1985-11-00 ·Pages 605-10

Kluft C, Verheijen JH, Jie AF, Rijken DC, Preston FE, Sue-Ling HM, Jespersen J, Aasen AO

Abstract

The plasma activity level of the recently discovered fast-acting inhibitor of tissue-type plasminogen activator (t-PA) was found to be temporarily increased after surgery, myocardial infarction and severe trauma. Detailed analysis of the postoperative period revealed simultaneously increased t-PA antigen and inhibition and decreased t-PA activity only on the first postoperative day. These changes were more rapid than those in fibrinogen and C-reactive protein. It is concluded that t-PA inhibition shows the most rapidly changing pattern observed so far in response to trauma. The postoperative fibrinolytic shutdown in blood fibrinolytic activity can be ascribed to a primary increase in t-PA inhibitor levels.

MeSH Terms
Antigens/analysis Fibrinolysis Fractures, Bone/blood Humans Postoperative Period Tissue Plasminogen Activator/antagonists & inhibitors,blood,immunology
Chemicals
Antigens Tissue Plasminogen Activator
Authors & Affiliations
8 authors, click to expand affiliations / ORCID
Kluft C
Verheijen J H
Jie A F
Rijken D C
Preston F E
Sue-Ling H M
Jespersen J
Aasen A O
Article Info
Journal
Scandinavian journal of clinical and laboratory investigation
Abbr.
Scand J Clin Lab Invest
ISSN
0036-5513
Published
1985-11-00
Pages
605-10
Language
English
Region
England
NLM ID
0404375
Subset
IM
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: product@genelibs.com